Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the coverage of the most important and influential journals to meet the needs of the global scientific community.  
ASCI Database
308-Lasani Town,
Sargodha Road,
Faisalabad, Pakistan
Fax: +92-41-8815544
Contact Via Web
Suggest a Journal
Articles by Bolanle A. Adeniyi
Total Records ( 3 ) for Bolanle A. Adeniyi
  Bolanle A. Adeniyi , B.C. Onwubuche , F. M. Anyiam , O. Ekundayo and Gail B. Mahady
  Helicobacter pylori is the primary etiologic agent of peptic ulcer, duodenal ulcer, chronic gastritis, gastric adenocarcinoma and related gastroduodenal disorders. Current triple therapy, including antibiotics and proton-pump inhibitors, has been successful; however, adverse events, non-patient compliance and consequent relapse of Helicobacter pylori infections are common. Crude methanol extracts of Eucalyptus gran-dis Hill ex. Maiden (Myrtaceae) stem bark were screened against a standard strain ATCC 43504 and ten clinical strains of H. pylori using the agar diffusion method on Mueller-Hinton agar supplemented with defibrinated horse blood and grown in a microaerophilic incubator. All the strains except UCH 97002 and UCH 98020 were inhibited by the extract to varying degrees. The minimum inhibitory concentration (MIC) against the susceptible strains tested ranged from 0.39 and 1.56 μg/mL. The urease activity of the three H. pylori strains tested decreased with increasing concentrations of the extract. The greatest inhibition of urease activity was observed in clinical strain UCH 97009. In addition, methanol extracts of the E. grandis enhanced cell aggregation of seven of the H. pylori strains leading to a decrease in the cell surface hydrophobicity. The salt aggregation test titer decreased from >3 to <1.5 for five of the strains and to <3 for two of the strains. Phytochemical screening of the plant revealed the presence of tannins, essential oils and saponins, while alkaloids were not detected. The anti-Helicobacter pylori activity observed in this study correlates well with the traditional use of this plant in Nigeria.
  Kristen Gaus , Yue Huang , Dawn A. Israel , Susan L. Pendland , Bolanle A. Adeniyi and Gail B. Mahady
  Previous investigations demonstrated that a standardized extract of ginger rhizome inhibited the growth of Helicobacter pylori in vitro with a minimum inhibitory concentration in the range 0.78 to 12.5 μg/mL. In the present work, the extract was tested in a rodent model of H. pylori-induced disease, the Mongolian gerbil, to examine the effects of the extract on both prevention and eradication of infection. The extract was administered to Mongolian gerbils at a daily dose of 100 mg/kg body weight in rations either 3 weeks prior to infection or 6 weeks post-infection. Treatment with the standardized ginger extract reduced H. pylori load as compared with controls and significantly (P<0.05) reduced both acute and chronic muscosal and submucosal inflammation, cryptitis, as well as epithelial cell degeneration and erosion induced by H. pylori. Importantly, the extract did not increase morbidity or mortality. Further investigations of the mechanism demonstrated that the ginger extract inhibited the activity of cyclooxygenase-2, with 50% inhibitory concentration (IC50) of 8.5 μg/mL in vitro, inhibited the nuclear factor-κβ transcriptional response in kBZ Jurkat cells (human T lymphocytes) with an IC50 of 24.6 μg/mL, and significantly inhibited the release of interleukin (IL)-1β, IL-6, IL-8, and tumor necrosis factor-α from lipopolysaccharide-stimulated human peripheral blood mononuclear cells with IC50 values of 3.89, 7.7, 8.5, and 8.37 μg/mL, respectively. These results suggest ginger extracts may be useful for development as agents to reduce H. pylori-induced inflammation and as for gastric cancer chemoprevention.
  Temitope O. Lawal , Bolanle A. Adeniyi , Aremu O. Adegoke , Scott G. Franzblau and Gail B. Mahady
  Context: Eucalyptus camaldulensis Dehnh. (Myrtaceae) and Eucalyptus torelliana F. Muell are used in Nigerian traditional medicine for the treatment of cough associated with tuberculosis (TB) and other respiratory infections. Objective: Hexane, chloroform, methanol extracts, and isolated compounds of E. camaldulensis and E. torelliana were screened for activity against Mycobacterium tuberculosis H37Rv (MtbH37Rv) to authenticate the traditional use of these plants. Materials and methods: The microplate alamar blue assay (MABA) method was used to investigate the anti-M. tuberculosis activities. Bioassay-guided fractionation of the hexane extract of E. torelliana leaf was performed, and isolated compounds were characterized by MS, 1D- and 2D-NMR. Results: The extracts inhibited the growth of MtbH37Rv [minimum inhibitory concentration (MIC) 4−64 μg/mL]. Spectroscopic characterization led to the identification of two compounds, hydroxymyristic acid methylester (1) and a substituted pyrenyl ester, a sterol (2). Compounds 1 and 2 had MIC of 49.45 and 46.99 μg/mL; IC50 >100 and 38.21 μg/mL; selectivity index (SI) >2.02 and 0.81, respectively, and a minimum bactericidal concentration (MBC) of 62.50 μg/mL. Discussion and conclusions: The anti-TB activities of these plants on M. tuberculosis H37Rv support their use in traditional medicine for the treatment of coughs associated with TB and reveals the presence of anti-Mtb active compounds in the plants. These findings not only demonstrate a new potential area of therapeutic value of E. camaldulensis and E. torelliana, but also illustrate the role of esters as anti-Mtb active principles in ethnobotanical preparations and as lead compounds in the development of new and effective anti-Mtb drugs.
Copyright   |   Desclaimer   |    Privacy Policy   |   Browsers   |   Accessibility